Author:
Tang Yu,Wang Wei,Teng Xiu-Zhi,Shi Lin
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Belani CP. Optimizing chemotherapy for advanced non-small cell lung cancer: focus on docetaxel. Lung Cancer. 2005;50 Suppl 2:S3–8.
2. Shirasaka T, Nakano K, Takechi T, Satake H, Uchida J, Fujioka A, et al. Antitumor activity of l M tega—fur-O.4 M5一ehloro-2.4-dihydroxypyridine一1 M potassium oxonate (S-1)against human colon carcinoma orthotopically implanted into nude rats. Cancer Res. 1996;56:2602–6.
3. Rieeiardi S, Tomao S. deMarinis F. Pemetrexed as first line therapy for non squamous non-small cell lung cancer [J]. Biomed Pharmacother. 2013;67(8):763–9.
4. Ichinose Y, Yoshimori K, Sakai H, Nakai Y, Sugiura T, Kawahara M, et al. S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial [J]. Clin Cancer Res. 2004;10(23):7860–4.
5. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, et al. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer [J]. N Engl J Med. 2002;10(346):92–8.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献